Previous close | 0.6605 |
Open | 0.6265 |
Bid | 0.5760 x 0 |
Ask | 0.7235 x 0 |
Day's range | 0.6265 - 0.6265 |
52-week range | 0.4362 - 1.3300 |
Volume | |
Avg. volume | 709 |
Market cap | 103.661M |
Beta (5Y monthly) | 0.65 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Key Insights Significant control over Vaxart by retail investors implies that the general public has more power to...
Vaxart, Inc. (NASDAQ:VXRT) shares traded higher in the premarket session on Friday, up more than 23% at one point. Vaxart’s average session volume was about 1.6 million. Friday premarket’s session volume had exceeded four million at the time of writing. Yesterday, Vaxart obtained a project award worth $453 million through the Rapid Response Partnership Vehicle, supported by the Biomedical Advanced Research and Development Authority under the Administration for Strategic Preparedness and Response